Bioengineering is topic for Cornell Society of Engineers annual conference April 10-12

ITHACA, N.Y. -- The biological applications of engineering, or bioengineering, is the topic of the 1997 Cornell Society of Engineers annual conference April 10-12 at Cornell University.

Featuring Richard A. Hazleton, chairman and CEO of Dow Corning Corp., and Samuel Fleming, chairman and CEO of Decision Resources Inc., the conference "Frontiers in Bioengineering" will highlight research in the rapidly developing field. Featured will be speakers from the Cornell faculty and from industry.

Hazleton, the Dow chairman who arrived there in the midst of the silicone breast implant controversy, will give the keynote address, "Science, Public Policy and Ethics in Biomaterials," at a dinner beginning at 7:15 p.m. Friday in the Statler Hotel Terrace Restaurant. Hazleton has appeared frequently on national television and has testified before Congress on the silicone breast implant controversy.

The conference kicks off with a talk at 9:25 a.m. Friday, "The Commercial Impact of Biotechnology: What's in Store for the Next 10 Years," by Samuel Fleming (Chem. Eng. '62), chairman and CEO of Decision Resources Inc. His firm, formerly a subsidiary of Arthur D. Little Inc., provides international market forecasting and evaluation for health care, information technology and process industries. His company now has offices on three continents, with more than 500 clients worldwide.

"Bioengineering is the next great frontier for engineers. Increasingly, biological systems are being used to produce new materials and engineers are learning how to intevene in biological processes," said Karl Miller, (Elec. Eng. '64), conference co-chair.

The conference features workshops on the biotechnology industry and financing and will feature research presentations by Cornell faculty working in bioengineering-related projects. Tours of Cornell engineering research centers and laboratories also will be available. The program is sponsored by the College of Engineering and the Cornell Society of Engineers.

EDITORS: For exact times and locations, please call Jeanne Subialka, conference registrar, (607) 255-9920, or visit http://www.engr.cornell.edu/Newsline/Newsline.html via the World Wide Web.

Preconference proceedings begin at 4:30 p.m. Thursday, April 10, with an engineering manufacturing seminar in 155 Olin Hall and a seminar by David Fischell, ('75 EP,'80 Ph.D.), founder and executive vice president of Isostent Inc., called "Bringing Innovation to Market: Experiences and Challenges of a Biomedical Device Entrepreneur."

Friday's events begin at 9:15 a.m. with sessions in the fourth floor computer training room in Rhodes Hall.

From noon to 1:30 p.m. Friday, John Hopcroft, the Joseph Silbert Dean of Engineering, will give a luncheon status report, "Educational and Research Program in the College of Engineering," followed by a talk on "Bioengineering at Cornell" by Michael Shuler, the Samuel B. Eckert Professor of Chemical Engineering and director of Cornell's Bioengineering Program, both in the Biotechnology Building.

More here:
Bioengineering is topic for Cornell Society of Engineers annual conference April 10-12